NICOYA年衍药业
/
← 专题阅读
专题阅读约 6 分钟阅读

免疫不好总生病,你可能缺骨化二醇?

免疫不好总生病,你可能缺骨化二醇?

维生素D是一种脂溶性开环固醇类激素前体,需经两次羟化才能成为具有生物活性的活性激素。首先,维生素D经25-羟化酶催化合成25⁃羟基维生素D [25(OH)D],即骨化二醇。骨化二醇是体内维生素D的主要储存形式,目前临床以骨化二醇水平是否充足作为维生素D是否缺乏的判断标准。25(OH)D再经1α-羟化酶作用,成为1,25⁃双羟维生素D [1,25(OH)2D],即骨化三醇。骨化三醇是维生素D的主要活性代谢产物,与维生素D受体 (vitamin D receptor, VDR )结合,发挥生理作用,又称活性维生素D。活性维生素D除了经典的钙磷调节作用之外,还具有强大的免疫调节特性,深度参与人体免疫系统的调控,在抗感染、抑制自身免疫反应、调节过敏中发挥重要作用[1]。

维生素D有助于维持免疫稳态

人体的免疫系统分为两大体系:固有免疫和特异性免疫。维生素D主要依靠VDR发挥免疫调节效应。树突状细胞、巨噬细胞、单核细胞、淋巴细胞等免疫细胞均表达VDR,是维生素D发挥免疫调控的分子基础。在固有免疫中,维生素D能够增强单核/巨噬细胞的趋化与吞噬能力,并诱导抗菌肽生成。可调控树突状细胞的成熟、活化、趋化能力与免疫刺激功能,同时影响固有淋巴样细胞和嗜酸性粒细胞的功能。在适应性免疫方面,维生素D可促进Th2细胞与调节性T细胞的发育,同时抑制Th1、Th17细胞的分化与活化;还能够调节B细胞活性以及IgE的产生。通过上述多条通路,维生素D有助于维持免疫稳态[2,3]。

维生素D与免疫系统[2]

骨化二醇水平不足与免疫相关性疾病

  1. 急性呼吸道感染

多项观察性研究分析显示,25(OH)D水平不足与呼吸道感染的发病以及严重程度相关。一项纳入8项研究、共15207名受试者的荟萃分析发现,维生素D缺乏可能与急性呼吸道感染病程延长相关[4]。问卷研究提示,25(OH)D每升高10 nmol/L,感染风险降低7%[5]。维生素D缺乏受试者,自述发生病毒性呼吸道感染的概率是维生素D充足人群的两倍[6]。维生素D缺乏的新兵、冬季训练的运动员,呼吸道疾病病程显著更长,维生素D缺乏也和呼吸道疾病严重程度相关[7,8]。另一项纳入25项RCT、11321名受试者的荟萃分析显示:每日或每周补充维生素D可降低呼吸道感染风险,尤其基线25 (OH) D<10 ng/mL的受试者[9]。

  1. 过敏性鼻炎

多项研究发现,过敏性鼻炎患者血清25(OH)D水平低于健康对照组。一项针对8012 名、18岁以上韩国成年人开展的全国大型调查,发现25 (OH) D水平越低,过敏性鼻炎患病率越高[10]。VDAART出生队列的二次分析显示,相比孕早晚期维生素D缺乏的母亲,孕期维生素D充足母亲的子代,3岁、6岁时发生过敏性鼻炎以及吸入性变应原致敏的风险更低[11]。另一项美国1248对母子的产前队列,发现妊娠前三个月、后三个月膳食维生素D每日摄入每增加100 IU,学龄期儿童罹患过敏性鼻炎的风险分别降低21%和20%[12]。Saad对120名埃及过敏性鼻炎患儿与100名健康儿童开展队列研究显示,中重度过敏性鼻炎患者平均25 (OH) D显著低于轻症患者,过敏性鼻炎组平均25 (OH) D水平与鼻部总症状评分和总IgE水平呈负相关[13]。

  1. 哮喘

一项横断面研究纳入69名活动性哮喘青少年和671名无喘息/无哮喘青少年,哮喘患儿平均25 (OH) D水平更低。同时,在过敏性哮喘人群中,维生素D水平和疾病严重程度呈负相关[14]。Bener等对比483名哮喘儿童与健康儿童,提出维生素D缺乏是儿童哮喘的主要预测因素[15]。英国一项纳入435040名成年人的横断面研究显示,相比维生素D缺乏,维生素D不足和充足人群的哮喘风险分别下降6.4%和9.8%,肺功能也得到改善[16]。

  1. 桥本甲状腺炎

大量观察性研究揭示25 (OH) D水平不足与桥本甲状腺炎发病风险升高存在潜在关联。多项研究显示,桥本甲状腺炎人群维生素D缺乏患病率显著高于健康对照,血清25 (OH) D水平与甲状腺自身抗体TGAb、TPOAb呈负相关,提示维生素D参与疾病发病机制。在全部桥本甲状腺炎病例中,甲减患者相比甲状腺功能正常患者,维生素D缺乏患病率更高、血清25 (OH) D水平更低[17-22]。

  1. 结核病

结核病患者普遍存在维生素D缺乏[23]。研究证实,1,25 (OH)₂D 可调控巨噬细胞功能,抑制胞内结核分枝杆菌增殖[24];维生素D信号通路可上调Toll样受体表达,诱导组织蛋白酶介导的胞内结核分枝杆菌杀伤效应[25]。暴露结核分枝杆菌的人群队列研究提示,补充维生素D可增强针对结核杆菌的免疫力[26,27]。一项荟萃分析包含1787例患者,发现补充维生素D组痰涂片转阴率、痰培养转阴率均上升,研究认为,肺结核患者治疗中可将维生素D作为联合辅助治疗选择[28]。

  1. 系统性红斑狼疮

多项观察性研究荟萃分析证实,系统性红斑狼疮人群维生素D缺乏患病率更高[29-31],25 (OH) D水平和狼疮疾病严重程度相关[32]。针对亚洲人群的荟萃分析提示,维生素D受体BsmI基因多态性与系统性红斑狼疮发病、狼疮性肾炎发病存在关联[33]。3项观察性试验的荟萃分析提示,补充维生素D可降低系统性红斑狼疮患者抗双链DNA抗体阳性率[34]。

  1. 多发性硬化

多发性硬化患者平均25 (OH) D水平显著更低,低维生素D状态与多发性硬化患病风险升高相关[35]。一项大型国际登记数据库,纳入46128名患者,累计随访351196患者年,证实童年时期所处纬度越高、预估中波紫外线暴露越低,成年后多发性硬化病情越重[36]。

  1. 炎症性肠病

两篇大样本荟萃分析,分别汇总64项、55项观察性研究显示,炎症性肠病患者维生素D缺乏患病率显著更高,25(OH)D水平和克罗恩病严重程度呈负相相关[37-38]。另一篇纳入27项研究的荟萃分析显示,低25(OH)D可作为炎症性肠病疾病活动度生物标志物,预测患者临床结局[39]。另有大量研究显示,25(OH)D水平不足与类风湿关节炎、幼年特发性关节炎、1型糖尿病、斑秃、银屑病和白癜风等多种免疫性疾病存在关联[40-43]。

如何高效、安全提升骨化二醇水平?

当前,能够提升25(OH)D水平的维生素D制剂种类较多,包括膳食营养性维生素D和前体储存性维生素D,各制剂作用特点和不良反应存在较大差异,见表1。膳食营养性维生素D吸收、分布、活化过程复杂多变,且因其脂溶性特性易大量沉积于脂肪组织,降低其肝脏转化效率,尤其针对合并肥胖、吸收不良以及肝功能不全的人群,常规剂量难以有效提升25(OH)D水平[44,45]。

骨化二醇是活性维生素D的激素前体,水溶性更强,无需经肝脏羟化,可快速提升25 (OH) D水平。普通人群中,同等剂量的骨化二醇提升25(OH)D的效率是维生素D3的2-5 倍,尤其适用于需要快速提升25(OH)D水平的人群[46]。骨化二醇包括速释制剂和缓释制剂。速释骨化二醇 (immediate release calcifediol, IRC)虽可纠正维生素D缺乏,但会激活维生素D的分解代谢通路,且会干扰钙磷代谢[47,48]。缓释骨化二醇(extended release calcifediol, ERC)可平稳、持续、有效提升25(OH)D水平,且对维生素D分解代谢、钙磷平衡及FGF-23干扰极小,为广大维生素D不足和缺乏人群提供了全面均衡的补充方案[49]。

表1. 不同种类维生素D制剂提升25(OH)D水平的效果差异[44,50]

评估参数

25(OH)D

Ca

P

FGF-23

治疗目标

↑↑↑

(−)

(−)

(−)

维生素D制剂种类

膳食营养性维生素D

维生素D2

↑

(−)

(−)

(−)

维生素D3

↑

(−)

(−)

(−)

前体储存性维生素D

IRC

↑↑↑

↑↑↑

↑↑↑

↑↑↑

ERC

↑↑↑

↑(−)

(−)

(−)

参考文献

中华医学会骨质疏松和骨矿盐疾病分会. 维生素D及其类似物的临床应用共识 (2025版). 中华骨质疏松和骨矿盐疾病杂志. 2025; 18(5): 497-517.

Panyu Zhang, Qingxiu Xu, Rongfei Zhu. Vitamin D and allergic diseases. Front Immunol. 2024; 15: 1420883.

Tomoka Ao, Junichi Kikuta, Masaru Ishii. The Effects of Vitamin D on Immune System and Inflammatory Diseases. Biomolecules. 2021; 11(11): 1624.

Min Xian Wang, Jiayun Koh, Junxiong Pang. Association between micronutrient deficiency and acute respiratory infections in healthy adults: a systematic review of observational studies. Nutr J. 2019; 18(1): 80.

Diane J Berry, Kathryn Hesketh, Chris Power, et al. Vitamin D status has a linear association with seasonal infections and lung function in British adults. Br J Nutr. 2011; 106(9): 1433-1440.

James R Sabetta, Paolo DePetrillo, Ralph J Cipriani, et al. Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One. 2010; 5(6): e11088.

Ilkka Laaksi, Juha-Petri Ruohola, Pentti Tuohimaa, et al. An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr. 2007; 86(3): 714-717.

Cheng-Shiun He, Michal Handzlik, William D Fraser, et al. Influence of vitamin D status on respiratory infection incidence and immune function during 4 months of winter training in endurance sport athletes. Exerc Immunol Rev. 2013; 19: 86-101.

Adrian R Martineau, David A Jolliffe, Richard L Hooper, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017; 15: 356: i6583.

Jae-Woo Jung, Ju-Young Kim, Sang-Heon Cho, et al. Allergic rhinitis and serum 25-hydroxyvitamin D level in Korean adults. Ann Allergy Asthma Immunol. 2013; 111(5): 352-357.

Yih-Chieh S Chen, Hooman Mirzakhani, Mengdi Lu, et al. The Association of Prenatal Vitamin D Sufficiency With Aeroallergen Sensitization and Allergic Rhinitis in Early Childhood. J Allergy Clin Immunol Pract. 2021; 9(10): 3788-3796.e3.

Supinda Bunyavanich, Sheryl L Rifas-Shiman, Thomas A Platts-Mills, et al. Prenatal, perinatal, and childhood vitamin D exposure and their association with childhood allergic rhinitis and allergic sensitization. J Allergy Clin Immunol. 2016; 137(4): 1063-1070.e2.

Khaled Saad, Abobakr Abdelmoghny, Mohamed Diab Aboul-Khair, et al. Vitamin D Status in Egyptian Children With Allergic Rhinitis. Ear Nose Throat J. 2020; 99(8): 508-512.

Ourania Kolokotroni, Anna Papadopoulou, Nicos Middleton, et al. Vitamin D levels and status amongst asthmatic and non-asthmatic adolescents in Cyprus: a comparative cross-sectional study. BMC Public Health. 2015;15: 48.

Abdulbari Bener, Mohammad S Ehlayel, Meri K Tulic, et al. Vitamin D deficiency as a strong predictor of asthma in children. Int Arch Allergy Immunol. 2012; 157(2): 168-175.

Yiqun Zhu, Danrong Jing, Huaying Liang, et al. Vitamin D status and asthma, lung function, and hospitalization among British adults. Front Nutr. 2022; 9: 954768.

Viktoria F Koehler, Natalie Filmann, W Alexander Mann. Vitamin D Status and Thyroid Autoantibodies in Autoimmune Thyroiditis. Horm Metab Res. 2019; 51(12): 792-797.

Gonca Tamer, Safiye Arik, Ismet Tamer, et al. Relative vitamin D insufficiency in Hashimoto's thyroiditis. Thyroid. 2011; 21(8): 891-896.

Nujen Colak Bozkurt, Basak Karbek, Bekir Ucan, et al. The association between severity of vitamin D deficiency and Hashimoto's thyroiditis. Endocr Pract. 2013; 19(3): 479-484.

Sandeep Appunni, Muni Rubens, Venkataraghavan Ramamoorthy, et al. Association between vitamin D deficiency and hypothyroidism: results from the National Health and Nutrition Examination Survey (NHANES) 2007-2012. BMC Endocr Disord. 2021; 21(1): 224.

Giovanni De Pergola, Vincenzo Triggiani, Nicola Bartolomeo, et al. Low 25 Hydroxyvitamin D Levels are Independently Associated with Autoimmune Thyroiditis in a Cohort of Apparently Healthy Overweight and Obese Subjects. Endocr Metab Immune Disord Drug Targets. 2018; 18(6): 646-652.

Elias E Mazokopakis, Maria G Papadomanolaki, Konstantinos C Tsekouras, et al. Is vitamin D related to pathogenesis and treatment of Hashimoto's thyroiditis? Hell J Nucl Med. 2015; 18(3): 222-227.

Mi Hyun Joo, Mi Ah Han, Sun Mi Park, et al. Vitamin D Deficiency among Adults with History of Pulmonary Tuberculosis in Korea Based on a Nationwide Survey. Int J Environ Res Public Health. 2017; 14(4): 399.

K A Rockett, R Brookes, I Udalova, et al. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun. 1998; 66(11): 5314-5321.

Philip T Liu, Steffen Stenger, Huiying Li, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006; 311(5768): 1770-1773.

Adrian R Martineau, Robert J Wilkinson, Katalin A Wilkinson, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med. 2007; 176(2): 208-213.

Davaasambuu Ganmaa, Edward Giovannucci, Barry R Bloom, et al. Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian school-age children: a randomized, double-blind, placebo-controlled feasibility trial. Am J Clin Nutr. 2012; 96(2): 391-396.

Hong-Xia Wu, Xiao-Feng Xiong, Min Zhu, et al. Effects of vitamin D supplementation on the outcomes of patients with pulmonary tuberculosis: a systematic review and meta-analysis. BMC Pulm Med. 2018; 18(1): 108.

Md Asiful Islam, Shahad Saif Khandker, Sayeda Sadia Alam, et al. Vitamin D status in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis. Autoimmun Rev. 2019; 18(11): 102392.

Xue-Rong Wang, Jian-Ping Xiao, Jing-Jing Zhang, et al. Decreased Serum/Plasma Vitamin D levels in SLE Patients: A Meta-Analysis. Curr Pharm Des. 2018; 24(37): 4466-4473.

Sang-Cheol Bae, Young Ho Lee. Association between Vitamin D level and/or deficiency, and systemic lupus erythematosus: a meta-analysis. Cell Mol Biol (Noisy-le-grand). 2018; 64(1): 7-13.

Shi-Yang Guan, Hong-Yan Cai, Peng Wang, et al. Association between circulating 25-hydroxyvitamin D and systemic lupus erythematosus: A systematic review and meta-analysis. Int J Rheum Dis. 2019; 22(10): 1803-1813.

Young Ho Lee, Sang-Cheol Bae, Sung Jae Choi, et al. Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep. 2011; 38(6): 3643-3651.

André Silva Franco, Thiago Quadrante Freitas, Wanderley M Bernardo, et al. Vitamin D supplementation and disease activity in patients with immune-mediated rheumatic diseases: A systematic review and meta-analysis. Medicine (Baltimore). 2017; 96(23): e7024.

Shurong Duan, Zheng Lv, Xiaoxue Fan, et al. Vitamin D status and the risk of multiple sclerosis: a systematic review and meta-analysis. Neurosci Lett. 2014; 570: 108-113.

Marianna Vitkova, Ibrahima Diouf, Charles Malpas, et al. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study. Neurology. 2022; 98(24): e2401-e2412.

Mehdi Sadeghian, Parvane Saneei, Fereydoun Siassi, et al. Vitamin D status in relation to Crohn's disease: Meta-analysis of observational studies. Nutrition. 2016; 32(5): 505-514.

Xi-Xi Li, Yang Liu, Jie Luo, et al. Vitamin D deficiency associated with Crohn's disease and ulcerative colitis: a meta-analysis of 55 observational studies. J Transl Med. 2019; 17(1): 323.

John Gubatan, Naomi D Chou, Ole Haagen Nielsen, et al. Systematic review with meta-analysis: association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2019; 50(11-12): 1146-1158.

Casey R Johnson, Tom D Thacher. Vitamin D: immune function, inflammation, infections and auto-immunity. Paediatr Int Child Health. 2023; 43(4): 29-39.

William B Grant, Sunil J Wimalawansa, Pawel Pludowski, et al. Vitamin D: Evidence-Based Health Benefits and Recommendations for Population Guidelines. Nutrients. 2025; 17(2): 277.

Teodoro Durá-Travé, Fidel Gallinas-Victoriano. Type 1 Diabetes Mellitus and Vitamin D. Int J Mol Sci. 2025; 26(10): 4593.

Lambros Athanassiou, Ifigenia Kostoglou-Athanassiou, Michael Koutsilieris, et al. Vitamin D and Autoimmune Rheumatic Diseases. Biomolecules. 2023; 13(4): 709.

Andrea Giustina, John P Bilezikian, Robert A Adler, et al. Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows. Endocr Rev. 2024; 45(5): 625-654.

Michael F Holick. Vitamin D deficiency. N Engl J Med. 2007; 357(3): 266-281.

Roberto Cesareo, Roberto Attanasio, Marco Caputo, et al. Italian Association of Clinical Endocrinologists (AME) and Italian Chapter of the American Association of Clinical Endocrinologists (AACE) Position Statement: Clinical Management of Vitamin D Deficiency in Adults. Nutrients. 2018; 10(5): 546.

Martin Petkovich, Glenville Jones. CYP24A1 and kidney disease. Curr Opin Nephrol Hypertens. 2011; 20(4): 337-344.

Martin Petkovich, Joel Melnick, Jay White, et al. Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation. J Steroid Biochem Mol Biol. 2015; 148: 283-289.

Stuart M Sprague, Paul W Crawford, Joel Z Melnick, et al. Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease. Am J Nephrol. 2016; 44(4): 316-325.

Spiros Arampatzis, Thomas Ernandez, Daniel Teta, et al. New insights into the management of secondary hyperparathyroidism in non-dialysis dependent chronic kidney disease: extended release calcifediol. J Nephrol. 2026; 39(3): 443-454.